Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.87 USD | -2.60% | -1.06% | -16.89% |
Mar. 29 | TherapeuticsMD, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Feb. 06 | Knight Therapeutics Announces Launch of Bijuva in Canada | MT |
Financials (USD)
Sales 2022 | 69.96M | Sales 2023 | 1.3M | Capitalization | 25.77M |
---|---|---|---|---|---|
Net income 2022 | 112M | Net income 2023 | -10M | EV / Sales 2022 | 0.34 x |
Net cash position 2022 | 29.31M | Net Debt 2023 | 3.68M | EV / Sales 2023 | 22.6 x |
P/E ratio 2022 |
0.47
x | P/E ratio 2023 |
-2.28
x | Employees | 1 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 96.22% |
1 day | +2.13% | ||
1 week | +1.59% | ||
Current month | -16.16% | ||
1 month | -16.16% | ||
3 months | -16.16% | ||
6 months | -10.28% | ||
Current year | -14.67% |
Managers | Title | Age | Since |
---|---|---|---|
Marlan Walker
CEO | Chief Executive Officer | 50 | 13-05-31 |
Joseph Ziegler
DFI | Director of Finance/CFO | - | 23-08-16 |
Corporate Officer/Principal | - | 18-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Tommy Thompson
CHM | Chairman | 81 | 12-04-15 |
Cooper Collins
BRD | Director/Board Member | 45 | 12-02-27 |
Gail Naughton
BRD | Director/Board Member | 69 | 20-03-19 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 1.87 | -2.60% | 10 579 |
24-04-24 | 1.92 | +2.13% | 14,863 |
24-04-23 | 1.88 | 0.00% | 20,731 |
24-04-22 | 1.88 | +1.08% | 19,137 |
24-04-19 | 1.86 | -1.59% | 10,363 |
Delayed Quote Nasdaq, April 24, 2024 at 04:00 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-14.67% | 22.14M | |
+4.13% | 70.78B | |
+10.72% | 9.15B | |
-15.34% | 4.84B | |
+34.54% | 4.22B | |
+5.09% | 3.92B | |
+20.00% | 2.55B | |
-28.33% | 2.24B | |
-24.15% | 2.26B | |
+6.23% | 1.92B |
- Stock Market
- Equities
- TXMD Stock